KEGG: spo:SPBC32F12.07c
What is SPBC32F12.07c and what is its functional classification in S. pombe?
SPBC32F12.07c is an uncharacterized RING finger protein in Schizosaccharomyces pombe classified as a ubiquitin-protein ligase E3 of the MARCH (Membrane-Associated RING-CH) family . The protein contains a C3HC4 type (RING) zinc finger domain that likely mediates protein-protein interactions .
The full-length protein consists of 340 amino acids with multiple functional domains, including the characteristic RING finger domain essential for E3 ligase activity. As a putative E3 ubiquitin ligase, SPBC32F12.07c likely participates in the ubiquitin-proteasome system, targeting specific proteins for ubiquitination and subsequent degradation or altered function.
Sequence analysis reveals it shares homology with other RING finger E3 ubiquitin ligases, suggesting conservation of function across species, though its specific biological role in S. pombe remains to be fully characterized .
How is the genome of S. pombe organized and what significance does this have for SPBC32F12.07c research?
S. pombe has a relatively compact genome distributed across three chromosomes with approximately 5,000 protein-coding genes. The genome displays an uneven pattern of sequence variants with variant-rich regions occupying about half of the nuclear genome (50.3% of the 5-kb windows have more than ten SNPs) .
The SPBC32F12.07c gene is located on chromosome II and was identified during sequence analysis of a 39,648 bp segment contained in cosmid c32F12 from the right arm of chromosome II . This region contains 15 non-overlapping open reading frames longer than 300 bp. Understanding this genomic context is crucial for:
Designing specific primers for PCR amplification
Creating targeted genetic modifications
Analyzing potential co-regulated genes in the same chromosomal region
Interpreting experimental data in relation to neighboring genes
Researchers should note that S. pombe exhibits a mosaic pattern of variant distribution similar to that observed in S. cerevisiae, potentially resulting from infrequent outcrossing between strains of distinct lineages .
What methodologies can be used to study SPBC32F12.07c expression patterns?
Multiple complementary approaches can be employed:
Transcriptional Analysis:
RT-PCR and qRT-PCR using primers specific to SPBC32F12.07c
RNA-Seq to measure expression levels across different conditions
Northern blotting for transcript size verification
Microarray analysis as used in studies of other S. pombe genes
Protein Detection:
Western blotting using commercial antibodies like the rabbit polyclonal antibody (CSB-PA524249XA01SXV-2)
GFP-tagging of SPBC32F12.07c for visualization and quantification
Proteomics approaches (mass spectrometry)
Expression Pattern Analysis:
Promoter-reporter fusions (e.g., with GFP or lacZ)
ChIP-seq to identify transcription factors regulating SPBC32F12.07c
Cell cycle synchronization to detect phase-specific expression patterns
When analyzing expression data, researchers should consider the baseline transcriptional profiling of wild-type S. pombe during vegetative growth as a reference point .
How can I design experiments to identify and validate the E3 ligase activity of SPBC32F12.07c?
A comprehensive approach to establish E3 ligase activity includes:
In vitro Ubiquitination Assays:
Purify recombinant SPBC32F12.07c protein (available commercially or self-expressed)
Perform in vitro ubiquitination reactions with:
Ubiquitin
E1 enzyme
Compatible E2 enzymes (test multiple E2s: UbcH5, UbcH6, Ubc4, etc.)
ATP regeneration system
Potential substrates or substrate library
Analyze ubiquitination by Western blotting or mass spectrometry
E3 Ligase Activity Validation:
Generate point mutations in the RING domain (particularly the conserved cysteine residues)
Compare wild-type and mutant activity in vitro
Perform structure-function analysis using domain deletion constructs
Substrate Identification Strategies:
Yeast two-hybrid screens for interacting partners
Co-immunoprecipitation coupled with mass spectrometry
Comparative proteomics in wild-type vs. SPBC32F12.07c knockout strains
BioID or proximity labeling approaches
For validation, researchers should examine whether SPBC32F12.07c can catalyze the formation of a high molecular weight ubiquitin smear in vitro, similar to what has been observed with other RING E3 ligases like RNF115 .
What approaches can be used to generate and validate knockout or knockdown strains for SPBC32F12.07c in S. pombe?
Generation Methods:
Homologous Recombination:
Design constructs with selectable markers flanked by homology regions
Transform S. pombe cells and select for integrants
Confirm correct integration by PCR and sequencing
CRISPR-Cas9 System:
Design guide RNAs targeting SPBC32F12.07c
Co-transform with Cas9 and repair template
Screen for successful editing events
Conditional Systems for Essential Genes:
Validation Approaches:
PCR confirmation of deletion/integration
RT-PCR and Western blotting to confirm absence of transcript/protein
Complementation with wild-type gene to restore phenotype
Phenotypic analysis including:
Growth assays under various conditions
Cell morphology examination
Stress response testing
Cell wall integrity assessment
For analyzing the phenotypes of SPBC32F12.07c mutants, researchers should consider methods such as bulk segregant analysis, which has been successfully used to study natural trait variations in S. pombe .
What experimental systems can be used to study protein-protein interactions of SPBC32F12.07c?
In vivo Interaction Methods:
Co-Immunoprecipitation (Co-IP):
Yeast Two-Hybrid (Y2H):
Create SPBC32F12.07c bait constructs
Screen against S. pombe cDNA libraries
Validate interactions with targeted Y2H assays
Proximity-Based Labeling:
BioID or TurboID fusion proteins to identify proximal proteins
APEX2-based proximity labeling
Analyze labeled proteins by mass spectrometry
In vitro Interaction Methods:
Pull-down Assays:
Express and purify recombinant SPBC32F12.07c
Perform pull-downs with cell lysates
Identify binding partners by mass spectrometry
Surface Plasmon Resonance (SPR):
Immobilize purified SPBC32F12.07c
Measure binding kinetics with potential partners
Determine binding affinities
Network Analysis:
Integrate data into interaction networks
Compare with other RING finger protein networks in S. pombe
To date, 13 interactors and 13 interactions have been identified for SPBC32F12.07c according to the BioGRID database , providing a starting point for further interaction studies.
How does SPBC32F12.07c compare to other characterized RING finger proteins in S. pombe and other yeasts?
SPBC32F12.07c belongs to the RING finger family of E3 ubiquitin ligases, which represents an ancient expansion in filamentous ascomycete genomes . Comparative analysis can be performed across several dimensions:
Structural Comparison:
SPBC32F12.07c contains the characteristic C3HC4 type RING finger domain
Like RNF115 (another RING finger protein), it likely uses the RING domain for E3 ligase activity
Unlike some RING fingers that function as part of Cullin-RING Ligase (CRL) complexes, SPBC32F12.07c may function independently
Functional Comparison:
Other RING finger proteins in S. pombe include:
Evolutionary Conservation:
RING finger domains are highly conserved across eukaryotes
Compare homology with RNF115/BCA2/Rabring7 which has been shown to regulate multiple cellular processes
Analyze conservation with tools like Yogy to identify potential functional homologs
Expression Patterns:
Like many RING finger proteins, SPBC32F12.07c may show condition-specific expression
Compare with bZIP transcription factor family members that have been extensively characterized in terms of expression patterns during vegetative growth
This comparative approach can provide insights into potential functions and regulatory mechanisms of SPBC32F12.07c based on better-characterized RING finger proteins.
What methodological approaches can be used to study the potential role of SPBC32F12.07c in cellular stress responses?
Since many RING finger E3 ubiquitin ligases are involved in stress responses , a systematic approach to determine SPBC32F12.07c's role could include:
Expression Analysis Under Stress:
qRT-PCR of SPBC32F12.07c under various stresses:
Oxidative stress (H₂O₂, menadione)
Heat shock
Nutrient limitation
DNA damage (UV, MMS, etc.)
Cell wall stress (Calcofluor white, SDS)
Western blotting to determine protein levels and modifications
Phenotypic Characterization:
Compare growth of wild-type and SPBC32F12.07c mutant strains under stress conditions
Analyze cellular morphology and viability
Examine cell cycle progression under stress
Molecular Response Analysis:
ChIP-seq to identify stress-responsive transcription factors that bind SPBC32F12.07c promoter
Transcriptome analysis (RNA-seq) of wild-type vs. mutant under stress
Proteome analysis focusing on stress response proteins
Functional Testing:
In vitro ubiquitination assays under stress-mimicking conditions
Identify stress-specific substrates or interacting partners
Test for genetic interactions with known stress response genes
Consider following methodologies similar to those used to study RNF115, which has been shown to catalyze ubiquitination of various substrates to modulate signaling pathways in response to viral infections, autoimmunity, cell proliferation, and tumorigenesis .
What techniques can be applied to determine the subcellular localization of SPBC32F12.07c?
Understanding the subcellular localization of SPBC32F12.07c is critical for inferring its function. Several complementary approaches can be used:
Live Cell Imaging:
GFP/mCherry/mNeonGreen tagging of SPBC32F12.07c
Time-lapse microscopy to track dynamic localization
Colocalization with organelle markers
Fixed Cell Methods:
Immunofluorescence using antibodies against SPBC32F12.07c or epitope tags
Electron microscopy with immunogold labeling for high-resolution localization
Super-resolution microscopy techniques (STORM, PALM)
Biochemical Fractionation:
Cell fractionation to separate organelles
Western blot analysis of fractions
Mass spectrometry-based organelle proteomics
Sequence-Based Prediction:
Analyze for localization signals (NLS, NES, transmembrane domains)
Use prediction algorithms for subcellular localization
Compare with localization patterns of homologs
Inducible Localization Systems:
Anchor-Away or Anchor-Out approaches for functional validation
Optogenetic tools to manipulate localization
Rapamycin-inducible dimerization systems
Researchers should consider that as a potential membrane-associated RING-CH (MARCH) family protein, SPBC32F12.07c might localize to cellular membranes , but experimental verification is essential.
How can I design experiments to identify the potential substrates of SPBC32F12.07c as an E3 ubiquitin ligase?
Identifying the substrates of an E3 ubiquitin ligase is crucial for understanding its biological function. A multi-faceted approach includes:
Global Proteomics Approaches:
Quantitative proteomics comparing wild-type and SPBC32F12.07c knockout/knockdown
Di-Gly remnant profiling to identify ubiquitination sites
Ubiquitin remnant profiling using K-ε-GG antibodies
Proteasome inhibition to identify accumulated substrates
Targeted Approaches:
Yeast two-hybrid or BioID to identify interacting proteins
In vitro ubiquitination assays with candidate substrates
Co-immunoprecipitation followed by ubiquitin blotting
Bioinformatic Prediction:
Analyze potential substrates based on motifs recognized by MARCH family E3 ligases
Examine expression correlation patterns
Compare with substrates of homologous E3 ligases
Validation Methods:
Ubiquitination assays with purified components
Mutational analysis of predicted ubiquitination sites
Half-life studies of candidate substrates in wild-type vs. mutant cells
Rescue experiments with lysine-to-arginine mutants of substrates
A systematic approach would be to first identify proteins whose levels or ubiquitination status change in SPBC32F12.07c mutants, then confirm direct ubiquitination in vitro, and finally validate the biological significance of this modification.
What are the best methods for studying the role of SPBC32F12.07c in cell cycle regulation and DNA damage response?
S. pombe is an excellent model for studying cell cycle and DNA damage response pathways. To investigate SPBC32F12.07c's potential roles:
Cell Cycle Analysis:
Synchronize cells using centrifugal elutriation, nitrogen starvation, or cdc mutants
Analyze SPBC32F12.07c expression and protein levels across the cell cycle
Examine cell cycle progression in SPBC32F12.07c mutants by flow cytometry
Microscopic analysis of septation index and nuclear division
DNA Damage Response:
Expose cells to DNA damaging agents (UV, MMS, hydroxyurea, etc.)
Assess sensitivity of SPBC32F12.07c mutants
Monitor checkpoint activation markers (Chk1 phosphorylation)
Analyze DNA repair efficiency using specialized assays
Recombination Studies:
Utilize established S. pombe recombination assays to study:
Homologous recombination efficiency
Non-homologous end joining
Single-strand annealing
Compare recombination rates in wild-type and SPBC32F12.07c mutant backgrounds
Genetic Interaction Analysis:
Create double mutants with known cell cycle/DNA damage genes
Perform synthetic genetic array (SGA) analysis
Test for epistatic relationships
The well-established mitotic recombination assays in S. pombe would be particularly valuable for determining if SPBC32F12.07c plays a role in DNA double-strand break repair or the resolution of stalled replication forks.
What are the optimal conditions for expression and purification of recombinant SPBC32F12.07c protein?
Based on available commercial recombinant proteins and standard protocols for RING finger proteins:
Expression Systems:
Insect cells: For better folding of complex eukaryotic proteins
Yeast: S. cerevisiae or Pichia pastoris for authentic post-translational modifications
Expression Constructs:
Consider adding solubility tags (MBP, GST, SUMO) if solubility issues arise
Include TEV or PreScission protease sites for tag removal
Optimization Parameters:
Induction conditions: IPTG concentration (0.1-1.0 mM)
Temperature: Lower temperatures (16-20°C) often improve folding
Duration: Extended expression (overnight) at lower temperatures
Media: Rich media (2xYT, TB) or minimal media for isotope labeling
Purification Strategy:
Affinity chromatography (IMAC for His-tagged proteins)
Ion exchange chromatography
Size exclusion chromatography for final polishing
Buffer Considerations:
Include reducing agents (DTT or β-mercaptoethanol) to maintain cysteine residues
Consider zinc supplementation for proper RING domain folding
Optimize pH and ionic strength for protein stability
Storage buffer: Tris/PBS-based buffer with 50% glycerol at pH 8.0
Quality Control:
Mass spectrometry to confirm identity
Activity assays to verify proper folding and function
Following reconstitution of lyophilized protein, it's recommended to add 5-50% glycerol (final concentration) and aliquot for long-term storage at -20°C/-80°C to avoid repeated freeze-thaw cycles .
How can I develop specific antibodies against SPBC32F12.07c for research applications?
Development of specific antibodies involves several critical steps:
Antigen Design:
Full-length protein: Recombinant full-length SPBC32F12.07c protein is available
Peptide antigens: Select unique, surface-exposed regions (avoid transmembrane domains)
Multiple epitopes: Target at least two different regions for validation
Production Methods:
Polyclonal antibodies: Immunize rabbits with recombinant protein or KLH-conjugated peptides
Monoclonal antibodies: Hybridoma technology using mice or rats
Recombinant antibodies: Phage display or yeast display technologies
Purification Strategies:
Affinity purification against the immunizing antigen
Negative selection against related proteins
Cross-adsorption to remove non-specific antibodies
Validation Methods:
Western blotting using wild-type and knockout/knockdown samples
Immunoprecipitation followed by mass spectrometry
Immunofluorescence comparing wild-type and mutant cells
Pre-adsorption controls with immunizing antigen
Commercial Options:
Pre-made antibodies are available (e.g., CSB-PA524249XA01SXV-2)
Custom antibody services from specialized providers
When developing antibodies, consider that commercially available antibodies like the rabbit polyclonal (CSB-PA524249XA01SXV-2) are purified by antigen affinity and suitable for applications like ELISA and Western blot .